HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matt Davies Selected Research

ozanezumab

1/2017Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Matt Davies Research Topics

Disease

1Liver Neoplasms (Liver Cancer)
10/2022
1Infections
10/2022
1Liver Diseases (Liver Disease)
10/2022
1Chronic Hepatitis B
10/2022
1Tuberculosis (Tuberculoses)
01/2019
1Stroke (Strokes)
01/2017
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2017
1Transitional Cell Carcinoma
01/2017
1Dyspepsia (Indigestion)
01/2017
1Respiratory Insufficiency (Respiratory Failure)
01/2017

Drug/Important Bio-Agent (IBA)

1Proteins (Proteins, Gene)FDA Link
10/2022
1Viral ProteinsIBA
10/2022
1GSK656IBA
01/2019
1Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA
01/2019
1Pharmaceutical PreparationsIBA
01/2017
1ozanezumabIBA
01/2017

Therapy/Procedure

1Therapeutics
10/2022